Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional peptides by genome reverse engineering.

Martin G Grigorov1, Peter J van Bladeren

  • 1Nestlé Research Center, BioAnalytical Science Department, CH-1000 Lausanne 26, Switzerland. martin.grigorov@rdls.nestle.com

Current Opinion in Drug Discovery & Development
|June 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Interindividual Human Variation in Bioactivation and DNA Adduct Formation of Estragole in Liver Predicted by Physiologically Based Kinetic/Dynamic and Monte Carlo Modeling.

Chemical research in toxicology·2016
Same author

Effect of Glucuronidation on the Potential of Kaempferol to Inhibit Serine/Threonine Protein Kinases.

Journal of agricultural and food chemistry·2016
Same author

The effect of glucuronidation on isoflavone induced estrogen receptor (ER)α and ERβ mediated coregulator interactions.

The Journal of steroid biochemistry and molecular biology·2015
Same author

The effect of quercetin and kaempferol aglycones and glucuronides on peroxisome proliferator-activated receptor-gamma (PPAR-γ).

Food & function·2015
Same author

Evaluation of the interindividual human variation in bioactivation of methyleugenol using physiologically based kinetic modeling and Monte Carlo simulations.

Toxicology and applied pharmacology·2015
Same author

Malabaricone C-containing mace extract inhibits safrole bioactivation and DNA adduct formation both in vitro and in vivo.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2014
Same journal

Microreactors for continuous processing – How close to commercial utility?

Current opinion in drug discovery & development·2010
Same journal

Synthesis of polyketide natural products and analogs as promising anticancer agents.

Current opinion in drug discovery & development·2010
Same journal

Enantioselective synthesis of substituted oxindoles and spirooxindoles with applications in drug discovery.

Current opinion in drug discovery & development·2010
Same journal

Eliminating pharmaceutical impurities: Recent advances in detection techniques.

Current opinion in drug discovery & development·2010
Same journal

Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.

Current opinion in drug discovery & development·2010
Same journal

Catalysis in aqueous media for the synthesis of drug-like molecules.

Current opinion in drug discovery & development·2010
See all related articles

Computational biology and high-throughput technologies accelerate drug discovery by reducing costs and fostering innovation. Genomic data enables the creation of novel bioactive peptides through computational analysis.

Area of Science:

  • Biochemistry
  • Computational Biology
  • Genomics

Background:

  • High-throughput analytical technologies and computational approaches are crucial for cost reduction and innovation in bioactive molecule discovery.
  • The life sciences industry requires novel research and development concepts and new sources of bioactive molecules to meet market demands.
  • The genomic revolution offers a rich source of information for developing new bioactive molecules.

Purpose of the Study:

  • To explore the integration of computational biology and chemistry with high-throughput technologies for efficient bioactive molecule discovery.
  • To investigate the potential of genomic data for identifying novel bioactive peptides.
  • To address the need for innovation in life science research and development.

Main Methods:

Related Experiment Videos

  • Utilizing computational biology and chemistry tools for data analysis.
  • Employing high-throughput analytical technologies in the discovery pipeline.
  • Applying computational dissection of genomic data to identify peptide sequences.

Main Results:

  • Demonstrated reduction in operational costs through integrated computational and high-throughput methods.
  • Identified novel bioactive peptides through the analysis of genomic information.
  • Fostered innovation across various stages of the drug discovery process.

Conclusions:

  • The synergy between computational approaches and high-throughput technologies significantly enhances the discovery of bioactive molecules.
  • Genomic data analysis is a powerful strategy for generating novel bioactive peptides.
  • Implementing new concepts in R&D is essential for the life sciences industry to maintain market competitiveness.